ArticleCancer chemotherapy and pharmacology2018

A population pharmacokinetic model of cabozantinib in healthy volunteers and patients with various cancer types.

Steven Lacy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.